73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Newly developed mathematical model could be used to predict cancer drug side effects in individuals

Newly developed mathematical model could be used to predict cancer drug side effects in individuals

byKobe UniversityA bar graph to show drug metabolism predictions for the anti-cancer agent Irinotecan (the gray bars are the predictions and the black bars are the actual results). The shorter t

Newly developed mathematical model could be used to predict cancer drug side effects in individuals

byKobe UniversityA bar graph to show drug metabolism predictions for the anti-cancer agent Irinotecan (the gray bars are the predictions and the black bars are the actual results). The shorter t
Researchers identify new genetic risk factors for persistent HPV infections

Researchers identify new genetic risk factors for persistent HPV infections

byUniversity of Maryland School of MedicineDistribution of binding affinity IC50 values by HLA-DRB1 allele category (A) all binding predictions (B) Excluding non-binders (lC50 > 5000 nM). Cre

Researchers identify new genetic risk factors for persistent HPV infections

byUniversity of Maryland School of MedicineDistribution of binding affinity IC50 values by HLA-DRB1 allele category (A) all binding predictions (B) Excluding non-binders (lC50 > 5000 nM). Cre
Skin cancer: New therapy option to prevent metastases

Skin cancer: New therapy option to prevent metastases

byMedical University of ViennaA, Invadopodia index of MMPi treated wells normalized to DMSO control in 3 independent screening plates as indicated; B, MTS signal values of B16-F10 and WM983C cel

Skin cancer: New therapy option to prevent metastases

byMedical University of ViennaA, Invadopodia index of MMPi treated wells normalized to DMSO control in 3 independent screening plates as indicated; B, MTS signal values of B16-F10 and WM983C cel
Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

December 2023Leah LawrencePatients with previously untreated acute myeloid leukemia (AML) who were not candidates for intensive chemotherapy experienced disease response when treated with a combinatio

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

December 2023Leah LawrencePatients with previously untreated acute myeloid leukemia (AML) who were not candidates for intensive chemotherapy experienced disease response when treated with a combinatio
Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance
CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece
New drug could unlock benefits of immunotherapy for more patients

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen

New drug could unlock benefits of immunotherapy for more patients

FEBRUARY 27, 2024byInstitute of Cancer ResearchAntitumor responses. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI175369A new drug could offer a powerful way to sen
The way genes are switched on in one-cell embryos may resemble the trigger for cancer

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

byUniversity of BathGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112023When an embryo is formed, its genes—donated by a fertilizing sperm and egg—are sil

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

byUniversity of BathGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112023When an embryo is formed, its genes—donated by a fertilizing sperm and egg—are sil
Colon cancer is being spotted in younger people, and at later stages

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant

Colon cancer is being spotted in younger people, and at later stages

by Steven ReinbergColon cancer continues to rise among younger U.S. adults, with the American Cancer Society reporting a doubling of cases in people younger than 55 in about 25 years.Also, significant
Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul

Residual cancer burden after neoadjuvant therapy can accurately predict breast cancer survival

byUniversity of Texas M. D. Anderson Cancer CenterW. Fraser Symmans, M.D. Credit: MD Anderson Cancer CenterResearchers from The University of Texas MD Anderson Cancer Center today reported resul
Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch

Experts assess promise of vamorolone to treat Duchenne muscular dystrophy

by IOS PressSkeletal muscle fibers. Credit: Berkshire Community College Bioscience Image Library / Public domainThe drug vamorolone (Agamree) has been hailed as a promising new drug to treat Duch
GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6

GZ17-6.02 with bexarotene kills mycosis fungoides cells: Study

by Impact Journals LLCCombined macroautophagy and CD95 death receptor signaling facilitate additional tumor cell killing by GZ17-6.02. Credit: 2024 Booth et al.A new research paper titled "GZ17-6